Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Singer

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Mutagenesis|March 11, 2011
Possibility of methodical bias in analysis of comet assay studies: Re: DNA damage detected by the alkaline comet assay in the liver of mice after oral administration of tetrachloroethylene. (Mutagenesis, 25, 133-138, 2010)Melanie Struwe, Andreas Zeller, Thomas Singer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2006
Nucleophilicities and carbon basicities of pyridinesFrank Brotzel, Bernhard Kempf, Thomas Singer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 2, 2013
Genotoxicity profile of azidothymidine in vitroAndreas Zeller, Julie Koenig, Georg Schmitt, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantationAndrea Berghofen, Thomas Singer, Bernd Krüger, et al.
Pharmacogenomics|May 11, 2005
Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety TestingPeter Kasper, Gerry Oliver, Beatriz Silva Lima, et al.
Chemical Research in Toxicology|May 4, 2011
Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitationsAlexander Hillebrecht, Wolfgang Muster, Alessandro Brigo, et al.
Mutation Research|June 1, 2005
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?Anke Lühe, Laura Suter, Stefan Ruepp, et al.
Toxicology and Applied Pharmacology|July 6, 2014
Genotoxicity testing of peptides: folate deprivation as a marker of exaggerated pharmacologyMelanie Guérard, Andreas Zeller, Matthias Festag, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Pharmaceutical Research|February 6, 2019
The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic AntibodiesJerome Egli, Tilman Schlothauer, Christian Spick, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Mutagenesis|March 11, 2011
Possibility of methodical bias in analysis of comet assay studies: Re: DNA damage detected by the alkaline comet assay in the liver of mice after oral administration of tetrachloroethylene. (Mutagenesis, 25, 133-138, 2010)Melanie Struwe, Andreas Zeller, Thomas Singer, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2006
Nucleophilicities and carbon basicities of pyridinesFrank Brotzel, Bernhard Kempf, Thomas Singer, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 2, 2013
Genotoxicity profile of azidothymidine in vitroAndreas Zeller, Julie Koenig, Georg Schmitt, et al.
Lancet (London, England)|March 11, 2015
Alemtuzumab induction therapy in kidney transplantationAndrea Berghofen, Thomas Singer, Bernd Krüger, et al.
Pharmacogenomics|May 11, 2005
Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety TestingPeter Kasper, Gerry Oliver, Beatriz Silva Lima, et al.
Chemical Research in Toxicology|May 4, 2011
Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitationsAlexander Hillebrecht, Wolfgang Muster, Alessandro Brigo, et al.
Mutation Research|June 1, 2005
Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?Anke Lühe, Laura Suter, Stefan Ruepp, et al.
Toxicology and Applied Pharmacology|July 6, 2014
Genotoxicity testing of peptides: folate deprivation as a marker of exaggerated pharmacologyMelanie Guérard, Andreas Zeller, Matthias Festag, et al.
Nature Reviews. Drug Discovery|March 23, 2010
The safety and side effects of monoclonal antibodiesTrevor T Hansel, Harald Kropshofer, Thomas Singer, et al.
Pharmaceutical Research|February 6, 2019
The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic AntibodiesJerome Egli, Tilman Schlothauer, Christian Spick, et al.
Pageof 9